Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-19-011243)

Filing Details

Accession Number:: 0001179110-19-011243
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-10-25 17:08:01
Reporting Period:: 2019-10-23

Accepted Time:: 2019-10-25 17:08:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1203346	Doug G Iiekking	3838 West Parkway Blvd Salt Lake City UT 84120	Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-10-23	673	$0.00	2,032	No	4	M	Direct
Common Stock	Disposition	2019-10-23	286	$77.92	1,746	No	4	F	Direct
Common Stock	Disposition	2019-10-25	1,746	$75.33	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2019-10-23	673	$0.00	673	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,666			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
On October 23rd, 2017, the reporting person was granted 2,691 restricted stock units, vesting at 25% on each 23rd of October thereafter.
Weighted average price $75.325. Price range in multiple transactions was $75.305 to $75.41 inclusively.